2/26/2021NMPA Announces Package Insert Revision of Misoprostol Tablets

2/26/2021CANbridge Pharma and Puma Biotech Agree to Terminate NERLYNX License...

2/25/2021AstraZeneca Gains Default Chinese IND Approval for Its Class 1 New Bio...

2/25/2021Snapshot of BMI System Financial Performance in 2020

2/25/2021Puma Biotech and Pierre Fabre Amend NERLYNX License Deal to Include G...

2/25/2021Harbour BioMed Announces Chinese IND Approval of for Combo Therapy of ...

2/24/2021Review of Chinese Import Chemical Drug IND Applications in 2020

2/24/2021Snapshot of MNC Products in the 2020 NRDL

2/23/2021Solentim Expands Gglobal Rreach, Opening New Operation in China

2/23/2021Graviton Enters into Global Licensing Agreement for ROCK2 Inhibitor fr...

2/23/2021Review of Chinese Pharma Deals, R&D and Regulatory Developments in 202...

2/22/2021How Foreign Companies Can Break Into China's Biosimilar Market and Rel...

2/22/2021The Race to the Top: Does China Have What It Takes?

2/22/2021IHS Markit: China Pharma in the Year of the Ox

2/22/2021Junshi Bio Wins Chinese Conditional Approval for 2nd Indication for T...

2/20/2021China Further Promotes TCM Development by Strengthening Scientific Res...

2/19/2021State Council Issues the Regulation on the Use of Medical Insurance Fu...

2/19/2021Recent Executive Moves

2/18/2021Junshi Bio Announces sNDA Acceptance for Toripalimab Combined with Ch...

2/18/20212020 Performance of Leading MNC Pharma Companies in China

2/17/2021U.S. Chamber Releases In-Depth Analysis of U.S.-China Economic Relatio...

2/17/2021CDE Issues the Technical Guidelines for Similarity Assessment and Indi...

2/12/2021Recent Executive Moves

2/10/2021CDE Issues Three Documents for Change Filings of Chemical Drugs and Bi...

2/9/2021NMPA Revises Packages Inserts of Thiamazole Formulations

2/9/2021NMPA Adds 72 Designated Core Laboratories to Support MedPharm Regulati...

2/9/2021Apollomics, Inc. and Edison Oncology Announce Licensing Agreement for ...

2/9/2021Lee's Pharma Announces Breakthrough Therapy Designation of Sorrento's ...

2/9/2021Betta Pharma Mulls US$800M Hong Kong IPO in the First Half

2/9/2021NDA for Amarin's VASCEPA (icosapent ethyl) Accepted in China

Page:73/333 Total number of articles:9989: [First][<<] [71] [72] [73] [74] [75] [>>] [End]